The Latest Stem Cell Industry Statistics Explained
The value of the global stem cell market was $9.38 billion in 2020.
The statistic stating that the global stem cell market was valued at $9.38 billion in 2020 represents the total monetary worth of the activities related to the production, research, development, and sale of stem cell-based products and services worldwide within that specific year. This figure serves as an important indicator of the size and significance of the stem cell industry, reflecting the growing interest and investment in this field of biotechnology and healthcare. The market value symbolizes the economic opportunities and potential advancements in regenerative medicine and therapeutic applications that stem cells offer for treating various diseases and conditions. Additionally, it highlights the increasing recognition and utilization of stem cells in scientific research and clinical settings, emphasizing their role in shaping the future of healthcare and medicine.
The stem cell market is projected to reach $15.63 billion by 2025.
The statistic “The stem cell market is projected to reach $15.63 billion by 2025” indicates the estimated value of the global stem cell market by the year 2025 based on current trends and forecasts. This figure implies significant growth in the stem cell industry, reflecting increasing interest and investment in stem cell research and applications across various fields such as regenerative medicine, drug development, and personalized healthcare. The projected market value underscores the potential impact of stem cell technologies in addressing unmet medical needs and driving innovation in healthcare, with implications for advancements in treatment options and disease management.
North America accounted for the largest market share in the global stem cell market in 2020.
This statistic indicates that North America held the highest proportion of market sales within the global stem cell market in 2020 compared to other regions worldwide. This suggests that the demand for stem cell products or services in North America exceeded that of other regions, reflecting the region’s leading position in terms of market share. Factors contributing to North America’s dominance could include a significant investment in research and development, advancements in stem cell technologies, favorable regulatory environments, and a strong healthcare infrastructure that supports the adoption of stem cell therapies. This information is valuable for stakeholders in the stem cell industry to understand market dynamics and opportunities for growth within the region.
Bone marrow transplant is the most common stem cell therapy, with over 1 million procedures done to date.
The statistic that bone marrow transplant is the most common stem cell therapy, with over 1 million procedures done to date, highlights the widespread use and importance of this medical procedure in treating various diseases. Bone marrow transplant involves replacing damaged or diseased stem cells with healthy ones from a donor, typically used to treat conditions such as leukemia, lymphoma, and other blood-related disorders. The sheer volume of over 1 million procedures underscores the significant impact this therapy has had on patients’ lives and underlines its efficacy in improving outcomes and extending lifespans for those in need of stem cell treatments. This statistic further emphasizes the critical role that bone marrow transplant plays in modern healthcare and the ongoing advancements in stem cell therapy.
In the period of 2018-2020, more than 600 new clinical studies concerning stem cells were registered.
The statistic suggests a significant level of interest and activity in the field of stem cell research between 2018 and 2020, with over 600 new clinical studies being registered during this period. This indicates a growing trend in the exploration and application of stem cells for various medical purposes, such as regenerative medicine and disease treatment. The large number of registered studies also points to the potential promising opportunities and advancements that may arise from the research conducted within this timeframe, contributing to the broader scientific understanding and potential therapeutic applications of stem cells.
The global market for stem cell manufacturing is expected to reach $16.51 billion by 2025.
The statistic indicates that the global market for stem cell manufacturing is projected to grow significantly and reach a value of $16.51 billion by the year 2025. This rise in market value reflects the increasing demand and economic opportunities within the field of stem cell research and production. Factors driving this growth may include advancements in biotechnology, growing investments in healthcare, and the expanding applications of stem cells in various industries such as regenerative medicine and drug discovery. The substantial market size forecasted suggests a promising future for the stem cell manufacturing industry, with the potential for further innovation and development in the coming years.
Stem cell banking market is predicted to reach $13.69 billion by 2027.
This statistic implies that the market for stem cell banking services is projected to experience substantial growth, with an estimated value of $13.69 billion by the year 2027. This prediction suggests a positive trend in the industry, indicating increasing recognition and adoption of stem cell banking services for medical and research purposes. Factors contributing to this growth may include advancements in stem cell technology, rising awareness of the potential benefits of stem cell therapies, and an expanding market for personalized medicine. The forecasted market value reflects significant potential opportunities for stakeholders in the stem cell banking sector.
Asia Pacific is expected to witness the fastest growth in the stem cell industry through 2027.
The statistic that Asia Pacific is expected to witness the fastest growth in the stem cell industry through 2027 suggests that the region is anticipated to experience significant expansion and advances in the development and utilization of stem cell technologies over the next few years. This growth is likely driven by factors such as increasing investment in research and development, expanding healthcare infrastructure and access to advanced medical treatments, as well as a growing emphasis on regenerative medicine and personalized healthcare solutions in the region. The projection highlights the potential for Asia Pacific to emerge as a key player in the global stem cell industry, with opportunities for innovation, collaboration, and economic growth within this rapidly evolving sector.
Cord blood accounts for over 50% of all stem cells stored globally.
The statistic that cord blood accounts for over 50% of all stem cells stored globally indicates that a significant portion of stem cell collections worldwide come from umbilical cord blood, which is collected from newborn babies at birth. Cord blood contains valuable stem cells that can be used in various medical treatments and therapies, making it a popular choice for storage among parents and healthcare providers. This statistic highlights the growing recognition of the importance of cord blood banking and the potential benefits of utilizing these stem cells for regenerative medicine and treating a wide range of diseases and conditions.
The global mesenchymal stem cells market size was USD 1.34 billion in 2020.
The statistic ‘The global mesenchymal stem cells market size was USD 1.34 billion in 2020’ indicates the total value of the market for mesenchymal stem cells worldwide during that year, representing the revenue generated from the sale of these cells. Mesenchymal stem cells are a type of multipotent adult stem cell with the potential to differentiate into various cell types. The market size figure of USD 1.34 billion serves as a quantitative measure of the economic activity and growth opportunities within the industry related to mesenchymal stem cells, reflecting the demand for these cells in various biomedical and therapeutic applications such as regenerative medicine, drug discovery, and tissue engineering. This statistic provides insight into the scale and importance of the global mesenchymal stem cells market in 2020 and can inform stakeholders, investors, and policymakers about the market’s size and potential for future growth.
Over 20,000 scientific articles have been published on stem cells in the last decade.
The statistic ‘Over 20,000 scientific articles have been published on stem cells in the last decade’ indicates a significant amount of research activity and interest in the field of stem cells in the past ten years. This statistic highlights the growing body of scientific knowledge and the increasing research efforts dedicated to understanding the potential applications of stem cells in various fields such as regenerative medicine, development biology, and disease modeling. The sheer volume of scientific articles reflects the rapid progression of research in stem cell biology and the importance of this area of study in advancing our understanding of human health and disease.
Approximately 500,000 units of cord blood are currently stored in private banks worldwide.
The statistic reveals that there are approximately 500,000 units of cord blood that have been stored in private banks globally. Cord blood is collected from the umbilical cord just after childbirth and contains valuable stem cells that can be used in medical treatments for various diseases and conditions. The fact that half a million units have been stored indicates a substantial interest in the potential benefits of cord blood banking among parents and families. Storing cord blood in private banks allows individuals to have access to these stem cells in the future, either for personal use or for potential matches with others in need of a transplant. This statistic highlights the growing trend of families opting to preserve their cord blood as a form of medical insurance for potential future health needs.
Regenerative medicine, which includes stem cell therapies, is projected to be a $151 billion industry by 2021.
The statistic indicates that the field of regenerative medicine, encompassing approaches such as stem cell therapies, is expected to see substantial growth in the near future, with projections estimating its market size reaching $151 billion by the year 2021. This suggests a significant increase in both the adoption and investment in regenerative medicine technologies and treatments, driven by factors such as advancements in research, increasing acceptance of these innovative therapies, and the potential for addressing unmet medical needs. As a rapidly evolving and promising area within healthcare, regenerative medicine stands to play a crucial role in reshaping the future of medical treatments and offering new possibilities for addressing a wide range of health conditions.
Adult stem cells segment dominated the stem cell market in 2021.
The statistic “Adult stem cells segment dominated the stem cell market in 2021” indicates that within the broader stem cell market, adult stem cells were the most prevalent and influential category in terms of revenue, research focus, or overall market share in the year 2021. The dominance of adult stem cells suggests that this category, which includes mesenchymal stem cells, hematopoietic stem cells, and others sourced from adult tissues, outpaced other types of stem cells such as embryonic or induced pluripotent stem cells in terms of commercial applications, therapeutic developments, or research initiatives during the specified period. This statistic reflects the prominence and importance of adult stem cells in driving advancements and opportunities within the stem cell industry throughout the year 2021.
The human stem cell market in India is expected to grow at a CAGR of 26.05% during 2021-2026.
This statistic indicates that the human stem cell market in India is projected to experience significant growth over the period of 2021-2026, with a Compound Annual Growth Rate (CAGR) of 26.05%. The CAGR represents the average annual growth rate of the market during this five-year period. A CAGR of 26.05% suggests a rapid expansion in the market size and indicates a strong and positive trend in the demand for human stem cell products and services in India. This growth rate is higher than the general economic growth rate, indicating a potentially lucrative and dynamic market for stem cell technology in the country.
China’s stem cell market is predicted to boom to over 40 billion yuan (around $6.19 billion) in 2022.
The statistic indicates that the market for stem cell products and services in China is projected to experience significant growth, reaching a value of over 40 billion yuan (approximately $6.19 billion) by the year 2022. This prediction suggests a substantial increase in demand for stem cell-related products and services in China, reflecting a growing interest in stem cell research, healthcare applications, and potential therapeutic treatments. The booming stem cell market in China signals opportunities for investment, innovation, and advancements in the field of regenerative medicine within the country, with potential implications for healthcare delivery, biotechnology development, and economic growth.
There are over 430,000 recorded units of cord blood and cord tissue stem cells stored in the U.S.
The statistic that there are over 430,000 recorded units of cord blood and cord tissue stem cells stored in the U.S. indicates a significant prevalence of stem cell banking among individuals and families seeking to preserve these valuable biological materials for potential future use. Cord blood and cord tissue stem cells are known for their therapeutic potential in treating various diseases and conditions, making them a valuable resource for medical interventions. The large number of stored units suggests a growing awareness and acceptance of stem cell banking as a means of safeguarding health and harnessing the regenerative capabilities of these cells for potential medical treatments in the future.
As of 2020, more than 80 diseases have been treated using cord blood stem cells.
The statistic states that by the year 2020, over 80 different diseases had been successfully treated using cord blood stem cells. This suggests that cord blood stem cells have shown significant therapeutic potential in a wide range of medical conditions. Stem cells derived from cord blood are known for their ability to develop into various types of cells in the body, which makes them valuable in regenerative medicine and treating diseases that involve damaged or malfunctioning cells. The variety of diseases treated using cord blood stem cells highlights their versatility and effectiveness in providing potential cures or improvements in various health conditions.
References
0. – https://www.www.mordorintelligence.com
1. – https://www.parentsguidecordblood.org
2. – https://www.www.taiwannews.com.tw
3. – https://www.www.bccresearch.com
4. – https://www.www.cb-association.org
5. – https://www.www.alliedmarketresearch.com
6. – https://www.www.grandviewresearch.com
7. – https://www.www.business-standard.com
8. – https://www.www.fortunebusinessinsights.com
9. – https://www.www.transparencymarketresearch.com
10. – https://www.pubmed.ncbi.nlm.nih.gov
